Established in 2003 by Joy and Hugh P. McCormick and the McCormick family

HUGH P. McCORMICK JR., A&S 1942, is a retired executive of McCormick & Co., the international specialty food company founded in 1889 by his great-uncle. While a Hopkins undergraduate, he participated in the wrestling team and was captain of both the swimming and football teams. Mr. McCormick and his wife, JOY McCORMICK, completed funding of this professorship, initiated by his mother, Mary C. McCormick. In 1984, Joy and Hugh McCormick's daughter, Mary McCormick Meyer, first received care at the Hopkins Diabetes Center, spurring the family's interest and support. The McCormicks are intrigued by the rapid advances in stem cell research and are optimistic that one day scientists will find a cure for diabetes. (Mr. McCormick and Mary McCormick Meyer are pictured.)


SHERITA HILL GOLDEN, SPH ’00, is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism in the Division of Endocrinology and Metabolism at the Johns Hopkins University School of Medicine. She is Associate Professor of Medicine and also holds joint appointments in the Welch Center for Prevention, Epidemiology, and Clinical Research in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and in the Armstrong Institute for Patient Safety. She is the director of the Johns Hopkins Inpatient Diabetes Management Service and serves as chairperson of the Glucose Steering Committee for The Johns Hopkins Hospital.

Dr. Golden was raised in Upper Marlboro, Maryland. She graduated Phi Beta Kappa and summa cum laude from the University of Maryland, College Park, and Alpha Omega Alpha from the University of Virginia School of Medicine before training in Internal Medicine and Endocrinology and Metabolism at The Johns Hopkins Hospital. During her fellowship in endocrinology, she received a Master of Health Science degree in clinical epidemiology from the Johns Hopkins University Bloomberg School of Public Health where she was elected to the Delta Omega Public Health Honorary Society. She joined the faculty of the Division of Endocrinology and Metabolism in 2000 as a recipient of a prestigious Robert Wood Johnson Minority Medical Faculty Career Development Award.

The author of more than 70 articles, 12 book chapters, and four monographs, Dr. Golden’s primary research interest centers around identifying endocrine risk factors associated with the development of diabetes and cardiovascular disease through the incorporation of measures of hormonal function into the design of clinical trials of cardiovascular risk modification, observational studies of incident cardiovascular disease and diabetes, and studies evaluating diabetic complications. Dr. Golden’s research explores the role of hypothalamic-pituitary-adrenal (HPA) axis biomarkers in type 2 diabetes pathogenesis. She has made fundamental discoveries regarding hormonal determinants of the association between depression and type 2 diabetes, specifically HPA axis activation. She conducted the first epidemiological analyses in the Atherosclerosis Risk in Communities Study and Multi-Ethnic Study of Atherosclerosis demonstrating cross-sectional and longitudinal associations of depressive symptoms with type 2 diabetes. Her ground-breaking investigation demonstrating a bi-directional, longitudinal association between depression and type 2 diabetes spawned international collaborations to explore biological mechanisms. Recognizing the lack of direct data measuring HPA axis activity, Dr. Golden identified measures of subclinical HPA axis hyperactivity to incorporate into epidemiological studies. These measures have wide implications to the study of stress and chronic diseases.

Dr. Golden has also studied other molecular epidemiology aspects of type 2 diabetes, demonstrating that endogenous sex hormones in post-menopausal women are associated with atherosclerosis, insulin resistance, and incident type 2 diabetes. She received the Trudy Bush Fellowship for Cardiovascular Research in Women’s Health Award twice from American Heart Association for this work. Most recently, as a principal investigator of the Diabetes Prevention Program Outcome Study, Dr. Golden has been an active participant in the Sex Hormones in Post-menopausal Women Ancillary Study and has co-authored manuscripts examining the impact of the Diabetes Prevention Program (DPP) interventions on changes in sex hormones and glucose and lipid parameters in post-menopausal women.

Dr. Golden is a devoted mentor and currently serves as co-director of the Epidemiology and Clinical Research in Diabetes and Endocrinology Training Grant. She is also director of the Training Core for the Johns Hopkins Center to Eliminate Cardiovascular Health Disparities, where she has developed a cardiovascular health disparities curriculum for pre-doctoral students, post-doctoral fellows, and junior faculty and six-week cardiovascular health disparities undergraduate summer internship program.

Dr. Golden has several national leadership roles and previously served on an Institute of Medicine committee, ‘Living Well with Chronic Disease’. National and international recognitions of Dr. Golden are reflected by her participation in the NIH/NIDDK Diabetes Research Strategic Plan Diabetes Complications Subgroup (representing depression and cognitive disorders) and by her role as co-chairperson of NIDDK’s 2012 International Conference on Diabetes and Depression. She is an associate editor of Diabetes Care, the highest impact diabetes subspecialty journal. She has several national leadership roles, including chairperson of the American Diabetes Association Epidemiology and Biostatistics Interest Group and American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. In 2012, she led the Writing Group of the Endocrine Society’s first Scientific Statement on Disparities in Endocrine Disorders.